The Final Stages of Myelodysplastic Syndromes (MDS): What to Expect

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult a healthcare professional for guidance specific to your or your loved one’s condition.

Understanding Myelodysplastic Syndromes (MDS)

Myelodysplastic syndromes (MDS) are a group of cancers where the bone marrow fails to produce enough healthy, mature blood cells. Often called a "bone marrow failure disorder," MDS leads to a shortage of one or more types of blood cells:

• Red Blood Cells (Anemia): Causes fatigue, weakness, shortness of breath, and pale skin.
• White Blood Cells (Neutropenia): Weakens the immune system, leading to frequent and severe infections.
• Platelets (Thrombocytopenia): Impairs blood clotting, causing easy bruising, bleeding, and tiny red spots on the skin (petechiae).

MDS most commonly affects older adults, with the average age of diagnosis around 70. While some forms progress slowly, higher-risk MDS can be aggressive and may transform into acute myeloid leukemia (AML). Discussing the final stages of MDS is difficult, but understanding the process can help patients, families, and caregivers prepare and focus on providing comfort and support.

How MDS Progresses: Risk Categories, Not Stages

Unlike solid tumors classified by stages (I-IV), MDS is categorized using prognostic scoring systems. The most common is the Revised International Prognostic Scoring System (IPSS-R), which groups MDS into five risk categories from "Very Low" to "Very High." This score helps predict the disease's course and is based on:

• The percentage of immature "blast" cells in the bone marrow.
• The severity of low blood counts (cytopenias).
• Specific genetic abnormalities in the bone marrow cells.

Lower-risk MDS often progresses slowly, allowing for many years of life with supportive care. Higher-risk MDS can advance more quickly, with a greater chance of transforming into AML. Treatment, including medications like hypomethylating agents or a stem cell transplant (the only potential cure), can significantly alter this course. Good Morning America anchor Robin Roberts, who received a bone marrow transplant for MDS, is a well-known example of a successful outcome. However, for those who cannot receive a transplant or whose disease no longer responds to treatment, MDS can become terminal.

Complications Leading to End-of-Life in MDS

As MDS advances, the failing bone marrow leads to severe, life-threatening complications that are often the direct cause of death.

• Severe Anemia: Extreme fatigue and shortness of breath can strain the heart, leading to heart failure. Frequent blood transfusions may cause iron overload, which can damage organs if not managed.
• Life-Threatening Infections: A lack of healthy white blood cells makes the body vulnerable to infections. A minor illness can quickly escalate into pneumonia or sepsis (a body-wide infection), which are leading causes of death in MDS patients.
• Uncontrolled Bleeding (Hemorrhage): Critically low platelet counts can lead to spontaneous and severe bleeding, including in the gastrointestinal tract or the brain (hemorrhagic stroke).
• Progression to Acute Myeloid Leukemia (AML): About 20-30% of MDS cases, particularly high-risk ones, transform into AML. This aggressive cancer causes a rapid decline due to organ failure, infection, or bleeding.

"You matter because you are you, and you matter to the last moment of your life. We will do all we can, not only to help you die peacefully, but also to live until you die."
– Dame Cicely Saunders, founder of the modern hospice movement.

The Journey Through the Final Stages of MDS

While not a formal medical classification, the end-of-life process for MDS can be understood through general phases of decline. Every individual's journey is unique, but these patterns are common.

Early Phase (Months Before)

• Increasing Fatigue: The person tires more easily and needs more rest.
• Higher Transfusion Needs: Blood or platelet transfusions are required more frequently, and their benefits may not last as long.
• Symptom Management: Discussions about palliative care may begin to focus on managing symptoms and improving quality of life.

Mid Phase (Weeks to Months Before)

• Frequent Hospitalizations: Stays for infections or transfusions become more common.
• Physical Decline: Noticeable weight loss, muscle wasting, and a poor appetite may occur.
• Increased Need for Support: Help with daily activities like personal care, cooking, and mobility becomes necessary.

Advanced Phase (Weeks to Days Before)

• Severe Weakness: The person spends most of their time in bed or resting.
• Worsening Symptoms: Shortness of breath may occur even at rest. Bruising and bleeding can happen with little provocation.
• Pain and Discomfort: While MDS itself isn't always painful, complications like infections or bone pain (if AML develops) may require pain management.
• Emotional Withdrawal: The person may become less communicative and more withdrawn as they begin to detach emotionally and spiritually.

Final/Active Dying Phase (Days to Hours Before)

In the last days, the body begins its final, natural process of shutting down.

• Profound Weakness: The person is often unresponsive or drifts in and out of consciousness.
• Loss of Appetite: There is little to no interest in food or drink. This is a normal part of the process.
• Changes in Breathing: Breathing may become shallow, irregular, or produce a rattling sound (a "death rattle") due to the relaxation of throat muscles.
• Circulation Changes: Hands and feet may feel cool to the touch and appear bluish or mottled as circulation slows.
• Decreased Consciousness: The person may sleep most of the time. However, hearing is one of the last senses to fade, so speaking softly and holding their hand can be a great source of comfort.

The Role of Palliative Care and Hospice

Palliative care can be introduced at any stage of a serious illness to manage symptoms and improve quality of life. It is not just for the end of life. For MDS patients, it focuses on relieving fatigue, pain, and anxiety while supporting emotional and spiritual needs.

Hospice care is a specific type of palliative care for individuals with a life expectancy of six months or less. When curative treatments for MDS are no longer working or desired, hospice shifts the focus entirely to comfort and dignity. A hospice team provides expert medical care, emotional support, and spiritual guidance, usually in the patient's home.

Accepting hospice care is not "giving up"; it is a choice to prioritize quality of life, ensuring a person’s final days are as peaceful and meaningful as possible.

Coping with the Emotional Journey

Patients and their families often experience a range of powerful emotions, sometimes described by the Kübler-Ross model: denial, anger, bargaining, depression, and acceptance. These stages are not linear, and people may move between them.

Supporting Emotional Health:

• Open Communication: Create a safe space to talk about fears, wishes, and feelings.
• Support Groups: Connecting with others who understand the journey can reduce feelings of isolation. Organizations like the Leukemia & Lymphoma Society (LLS) and the Aplastic Anemia and MDS International Foundation (AAMDSIF) offer valuable resources.
• Professional Counseling: Therapists specializing in grief or chronic illness can provide coping strategies for both patients and caregivers.
• Create a Legacy: Some find comfort in writing letters, creating memory books, or sharing important life stories.

You can find helpful webinars and videos on coping with blood cancers on the Leukemia & Lymphoma Society website or its official YouTube channel.

Helpful Resources & Further Reading

For more detailed information and support, consult these reputable organizations:

• American Cancer Society: Provides a comprehensive guide to Myelodysplastic Syndromes, from diagnosis to treatment and coping.
• Leukemia & Lymphoma Society (LLS): Offers patient-friendly information, financial aid, and support services for those affected by MDS.
• Aplastic Anemia and MDS International Foundation (AAMDSIF): A dedicated resource for bone marrow failure diseases, providing education, support networks, and research updates.
• The MDS Foundation: Focuses on patient support, education for medical professionals, and MDS research.
• National Institute on Aging: Offers excellent guides on end-of-life care, palliative care, and hospice that are helpful for any terminal illness.